Skip to content

Evaluation of hemodynamic effects of cascade hemofiltration in septic shock

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20442117
Enrollment
60
Registered
2008-02-01
Start date
2008-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock/ hemofiltration Infections and Infestations Septic shock/ hemofiltration

Interventions

Either standard hemofiltration or Cascade hemofiltration (2 types of membrane evaluated)

Sponsors

Gambro Industries, Clinical Affairs Department (France)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with a septic shock diagnosed by the medical staff team 2. Patient mechanically ventilated and treated by high doses of catecholamines after adequate fluid administration (superior or equal to 1.0 mg/h of norepinephrine or epinephrine) for more than 120 minutes and <24h Note: Patients with renal failure (treated or not) can be included

Exclusion criteria

Exclusion criteria: 1. Age (years) 85 2. Weight >120 kg 3. Thrombocytopenia 5024h 6. Patient admitted to the Intensive Care Unit (ICU) superior or equal to 7 days before the inclusion criteria 7. Patient with intercurrent disease limiting his/her self-sufficiency (need of help before septic shock) 8. Inclusion (<28 days) in another study interfering with the goals of the current investigation 9. Pregnancy and patient under guardianship 10. Immune compromised patients (e.g., being treated for cancer, treated by immunosuppressors or steroids, AIDS)

Design outcomes

Primary

MeasureTime frame
Number of days without catecholamines at the 28th day of randomization

Secondary

MeasureTime frame
1. Rate of decrease of catecholamines during the first 72h 2. Number of days without mechanical ventilation at the 90th day 3. Number of days without Renal Replacement Therapy (RRT) at the 90th day 4. Number of days without ICU requirement at the 90th day 5. Death or survivor status at the 90th day

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026